Foghorn Therapeutics Inc. (FHTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Foghorn Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.13
+3.90% today
Market cap
$122M
Overall quality
51/100
Kronos AI 30-day
+143.5%
8 of 8 simulated paths end higher
Foghorn Therapeutics Inc. (FHTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $122M. It trades at $2.13, up 3.90% today. Its overall quality score is 51 out of 100, ranked against the whole US market. 7 analysts' average target of $5.00 implies +134.7% from today's price. Kronos AI's 30-day forecast is +143.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $5.00 |
| Low – high | $2.00 – $10.00 |
| Analysts | 7 |
| Upside to average | +134.7% |
Kronos AI 30-day forecast
| Expected close | $4.99 (+143.5%) |
| Likely range | +125.2% … +186.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 22 |
| Solvency | 51 |
| Growth | 79 |
| Overall | 51 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.